Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby (pictured), senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3. Photo via the White House

Two astronauts recently received Presidential Medals of Freedom from President Joe Biden for their leadership in space.

Ellen Ochoa, the former center director and astronaut at the NASA's Johnson Space Center in Houston, and Jane Rigby, senior project scientist for NASA’s James Webb Space Telescope, were honored at the White House on May 3.

Ochoa was recognized for her leadership at NASA Johnson and for being the first Hispanic woman in space. Rigby was honored for her work on leading NASA’s transformational space telescope.

Ochoa spent 30 years with NASA, which included being the 11th director of JSC, deputy center director of JSC, and director of Flight Crew Operations. She served on the nine-day STS-56 mission aboard the space shuttle Discovery in 1993, and became the first Hispanic woman in space. She flew four more times to space with STS-66, STS-96, STS-110, and more.

“I’m so grateful for all my amazing NASA colleagues who shared my career journey with me,” Ochoa says in a NASA news release.

Rigby has published 160 peer-reviewed publications. She has been recognized with various awards like NASA’s Exceptional Scientific Achievement Medal, the Fred Kavli Prize Plenary Lecture from the American Astronomical Society (AAS), and the 2022 LGBTQ+ Scientist of the Year from Out to Innovate. Currently, she is an astrophysicist at NASA’s Goddard Space Flight Center.

Part of Rigby’s Medal of Freedom honor is due to her role in the success of NASA’s Webb mission. Webb is considered the most powerful space telescope, which launched on Dec. 25, 2021.

“I am proud Ellen and Jane are recognized for their incredible roles in NASA missions, for sharing the power of science with humanity, and inspiring the Artemis Generation to look to the stars,” says NASA Administrator Bill Nelson in the release. “Among her many accomplishments as a veteran astronaut and leader, Ellen served as the second female director of Johnson, flew in space four times, and logged nearly 1,000 hours in orbit. Jane is one of the many wizards at NASA who work every day to make the impossible possible. The James Webb Space Telescope represents the very best of scientific discovery that will continue to unfold the secrets of our universe. We appreciate Ellen and Jane for their service to NASA, and our country.”

NASA has announced it's pushed back two historic missions — the first of which was originally planned for later this year. Photo via NASA/Ben Smegelsky

NASA postpones historic crew landing until 2026

Houston, we have a delay

Astronauts will have to wait until next year before flying to the moon and another few years before landing on it, under the latest round of delays announced by NASA on Tuesday.

The space agency had planned to send four astronauts around the moon late this year, but pushed the flight to September 2025 because of safety and technical issues. The first human moon landing in more than 50 years also got bumped, from 2025 to September 2026.

“Safety is our top priority," said NASA Administrator Bill Nelson. The delays will “give Artemis teams more time to work through the challenges.”

The news came barely an hour after a Pittsburgh company abandoned its own attempt to land its spacecraft on the moon because of a mission-ending fuel leak.

Launched on Monday as part of NASA's commercial lunar program, Astrobotic Technology's Peregrine lander was supposed to serve as a scout for the astronauts. A Houston company will give it a shot with its own lander next month.

NASA is relying heavily on private companies for its Artemis moon-landing program for astronauts, named after the mythological twin sister of Apollo.

SpaceX’s Starship mega rocket will be needed to get the first Artemis moonwalkers from lunar orbit down to the surface and back up. But the nearly 400-foot (121-meter) rocket has launched from Texas only twice, exploding both times over the Gulf of Mexico.

The longer it takes to get Starship into orbit around Earth, first with satellites and then crews, the longer NASA will have to wait to attempt its first moon landing with astronauts since 1972. During NASA’s Apollo era, 12 astronauts walked on the moon.

The Government Accountability Office warned in November that NASA was likely looking at 2027 for its first astronaut moon landing, citing Elon Musk’s Starship as one of the many technical challenges. Another potential hurdle: the development of moonwalking suits by Houston’s Axiom Space.

“We need them all to be ready and all to be successful in order for that very complicated mission to come together,” said Amit Kshatriya, NASA's deputy associate administrator.

NASA has only one Artemis moonshot under its belt so far. In a test flight of its new moon rocket in 2022, the space agency sent an empty Orion capsule into lunar orbit and returned it to Earth. It’s the same kind of capsule astronauts will use to fly to and from the moon, linking up with Starship in lunar orbit for the trip down to the surface.

Starship will need to fill up its fuel tank in orbit around Earth, before heading to the moon. SpaceX plans an orbiting fuel depot to handle the job, another key aspect of the program yet to be demonstrated.

NASA’s moon-landing effort has been delayed repeatedly over the past decade, adding to billions of dollars to the cost. Government audits project the total program costs at $93 billion through 2025.

The history-making team was announced at Ellington Field near Johnson Space Center in Houston. Photo via LinkedIn

NASA names four astronauts heading to the moon at Houston event

ready for liftoff

NASA and the Canadian Space Agency announced the four astronauts who will be onboard the Artemis II mission around the moon yesterday at an event at Ellington Field near NASA’s Johnson Space Center in Houston.

The 10-day mission is slated to put the first woman and the first person of color on the moon.

“For the first time in more than 50 years, these individuals – the Artemis II crew – will be the first humans to fly to the vicinity of the Moon. Among the crew are the first woman, first person of color, and first Canadian on a lunar mission, and all four astronauts will represent the best of humanity as they explore for the benefit of all,” says JSC Director Vanessa Wyche. “This mission paves the way for the expansion of human deep space exploration and presents new opportunities for scientific discoveries, commercial, industry and academic partnerships and the Artemis Generation.”

The crew assignments include:

  • Commander Reid Wiseman, who has logged more than 165 days in space in two trips. He previously served as a flight engineer aboard the International Station and most recently served as chief of the Astronaut Office from December 2020 until November 2022.
  • Pilot Victor Glover, who served as pilot on NASA’s SpaceX Crew-1 mission in 2021. This will be his second trip to space.
  • Mission Specialist 1 Christina Hammock Koch, who set the record for longest single spaceflight by a woman with a total of 328 days in space and participated in the first all-female spacewalks. This will be her second flight into space.
  • Mission Specialist 2 Jeremy Hansen, representing Canada. Hansen is a colonel in the Canadian Armed Forces and former fighter pilot and has served as Capcom in NASA's Mission Control Center at Johnson Space Center. He was the first Canadian to lead a NASA astronaut class. This will be his first flight into space.

Meet the four astronauts who will return humans to the moon. Photo courtesy of NASA

“NASA astronauts Reid Wiseman, Victor Glover, and Christina Hammock Koch, and CSA astronaut Jeremy Hansen, each has their own story, but, together, they represent our creed: E pluribus unum – out of many, one," NASA Administrator Bill Nelson said. "Together, we are ushering in a new era of exploration for a new generation of star sailors and dreamers–the Artemis Generation.”

Artemis II is slated to build upon the uncrewed Artemis I mission that was completed in December. The crew will be NASA's first to aboard the agency's deep space rocket, the Space Launch System, and Orion spacecraft. They will test the spacecrafts' systems to ensure they operate as planned for humans in deep space before setting course for the moon.

NASA's Artemis program collaborates with commercial and international partners with the goal of establishing a long-term presence on the moon. Lessons learned from the missions are planned to be used to send the first astronauts to Mars.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston engineers develop breakthrough device to advance spinal cord treatment

future of health

A team of Rice University engineers has developed an implantable probe over a hundred times smaller than the width of a hair that aims to help develop better treatments for spinal cord disease and injury.

Detailed in a recent study published in Cell Reports, the probe or sensor, known as spinalNET, is used to explore how neurons in the spinal cord process sensation and control movement, according to a statement from Rice. The research was supported by the National Institutes of Health, Rice, the California-based Salk Institute for Biological Studies, and the philanthropic Mary K. Chapman Foundation based in Oklahoma.

The soft and flexible sensor was used to record neuronal activity in freely moving mice with high resolution for multiple days. Historically, tracking this level of activity has been difficult for researchers because the spinal cord and its neurons move so much during normal activity, according to the team.

“We developed a tiny sensor, spinalNET, that records the electrical activity of spinal neurons as the subject performs normal activity without any restraint,” Yu Wu, a research scientist at Rice and lead author of the study said in a statement. “Being able to extract such knowledge is a first but important step to develop cures for millions of people suffering from spinal cord diseases.”

The team says that before now the spinal cord has been considered a "black box." But the device has already helped the team uncover new findings about the body's rhythmic motor patterns, which drive walking, breathing and chewing.

Lan Luan (from left), Yu Wu, and Chong Xie are working on the breakthrough device. Photo by Jeff Fitlow/Rice University

"Some (spinal neurons) are strongly correlated with leg movement, but surprisingly, a lot of neurons have no obvious correlation with movement,” Wu said in the statement. “This indicates that the spinal circuit controlling rhythmic movement is more complicated than we thought.”

The team said they hope to explore these findings further and aim to use the technology for additional medical purposes.

“In addition to scientific insight, we believe that as the technology evolves, it has great potential as a medical device for people with spinal cord neurological disorders and injury,” Lan Luan, an associate professor of electrical and computer engineering at Rice and a corresponding author on the study, added in the statement.

Rice researchers have developed several implantable, minimally invasive devices to address health and mental health issues.

In the spring, the university announced that the United States Department of Defense had awarded a four-year, $7.8 million grant to the Texas Heart Institute and a Rice team led by co-investigator Yaxin Wang to continue to break ground on a novel left ventricular assist device (LVAD) that could be an alternative to current devices that prevent heart transplantation.

That same month, the university shared news that Professor Jacob Robinson had published findings on minimally invasive bioelectronics for treating psychiatric conditions. The 9-millimeter device can deliver precise and programmable stimulation to the brain to help treat depression, obsessive-compulsive disorder and post-traumatic stress disorder.

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.